Ispaghula Husk Tillomed Laboratories Limited

Ispaghula Husk, the active ingredient in Ispaghula Husk Tillomed Laboratories Limited, is a bulk-forming laxative presented as a powder for oral use. It helps relieve occasional or chronic constipation by increasing stool bulk and water content, facilitating easier bowel movements.

GNH USA supplies Ispaghula Husk Tillomed Laboratories Limited as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ispaghula Husk is a bulk-forming laxative used to manage constipation by increasing stool bulk and water content.

- Constipation: Relieves occasional or chronic constipation by expanding stool volume and promoting regular bowel movements.

Common Side Effects: - Abdominal bloating: Mild distension of the abdomen. - Flatulence: Increased intestinal gas. - Abdominal cramps: Mild cramping sensations. - Increased stool frequency: More frequent bowel movements. - Mild diarrhea: Loose stools in some users. - Nausea: Slight feeling of queasiness.

Serious or Rare Side Effects: - Intestinal obstruction: Potential blockage if insufficient fluid is taken. - Allergic reaction: Rash, itching, or swelling. - Severe abdominal pain: Persistent or intense pain. - Rectal bleeding: Unexplained blood in stool. - Severe dehydration: Due to excessive fluid loss.

Before using Ispaghula Husk, consider the following precautions: - Dosage adjustment: Use with adequate fluid intake to prevent blockage. - Medical conditions: Caution in patients with bowel strictures, narrowing, or recent abdominal surgery. - Drug interactions: May affect absorption of other oral medications; separate administration by at least 1 hour. - Pregnancy and lactation: Consult a healthcare professional before use. - Age considerations: Use with care in elderly and children. - Store at ambient temperature: Keep in original container, protect from moisture and heat.

Ispaghula Husk may interact with certain medications. Monitor and adjust as needed.

Major Interactions (Avoid): - Lithium: Fiber may reduce lithium absorption; monitor serum levels. - Digoxin: Potential decrease in digoxin absorption; consider therapeutic monitoring.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: Fiber may blunt glucose control; monitor blood sugar. - Iron supplements: Reduced iron absorption; separate dosing by at least 2 hours. - Thyroid hormone replacement: May decrease levothyroxine absorption; separate dosing.